{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:46:36Z","timestamp":1773384396508,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The gastrin-releasing peptide receptor (GRPR) is overexpressed in the majority of primary prostate cancer lesions, with persistent expression in lymph nodes and bone metastases, making it a legitimate molecular target for diagnostic imaging and staging. This study presents the synthesis and preclinical evaluation of [<jats:sup>18<\/jats:sup>F]MeTz-PEG<jats:sub>2<\/jats:sub>-RM26, a GRPR antagonist which utilises the Inverse Electron Demand Diels-Alder (IEDDA) reaction for <jats:sup>18<\/jats:sup>F-labelling. This click-chemistry approach allows for site-specific incorporation of fluorine-18 under mild conditions, preserving the peptide\u2019s structural integrity and biological activity. Receptor specificity and affinity of [<jats:sup>18<\/jats:sup>F]MeTz-PEG<jats:sub>2<\/jats:sub>-RM26 were evaluated in vitro using GRPR-expressing PC-3 cells. Furthermore, the biodistribution profile of [<jats:sup>18<\/jats:sup>F]MeTz-PEG<jats:sub>2<\/jats:sub>-RM26 was assessed in NMRI mice and its tumour-targeting capability was investigated in mice bearing PC-3 xenografts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The labelling of TCO-PEG<jats:sub>2<\/jats:sub>-RM26 precursor involved three steps: (1) synthesis of an <jats:sup>18<\/jats:sup>F-labelled activated ester on a quaternary methyl ammonium (QMA) cartridge, (2) conjugation of the labelled ester to a tetrazine amine, and (3) attachment to TCO-PEG<jats:sub>2<\/jats:sub>-RM26 via an IEDDA click reaction. This production method of [<jats:sup>18<\/jats:sup>F]MeTz-PEG<jats:sub>2<\/jats:sub>-RM26 afforded a high apparent molar activity of 3.5\u20134.3 GBq\/\u00b5mol and radiochemical purity exceeding 98%, with 43\u201370 MBq activity incorporation, while the entire synthesis was completed within 75\u00a0min. Both in vitro and in vivo studies confirmed the specific binding of [<jats:sup>18<\/jats:sup>F]MeTz-PEG<jats:sub>2<\/jats:sub>-RM26 to GRPR, with a significant reduction in activity uptake observed upon receptor saturation. The radioligand exhibited rapid blood clearance and minimal bone uptake, confirming the stability of the fluorine-carbon bond. However, high hepatic uptake (12\u201313% IA\/g at 1\u00a0h post-injection) indicated predominant hepatobiliary excretion. Receptor-mediated uptake was observed in the tumours and pancreatic tissue, although the overall activity uptake in tumours was low, likely due to the rapid hepatobiliary clearance of [<jats:sup>18<\/jats:sup>F]MeTz-PEG<jats:sub>2<\/jats:sub>-RM26.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These findings demonstrate the effectiveness of the IEDDA click reaction for fluorine-18 labelling of GRPR-targeting PET tracers. Future studies should focus on increasing the hydrophilicity of the imaging probe to improve the targeting properties and biodistribution profile of the radioligand.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41181-025-00336-9","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T10:59:52Z","timestamp":1742986792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [18F]MeTz-PEG2-RM26 for positron emission tomography"],"prefix":"10.1186","volume":"10","author":[{"given":"Panagiotis","family":"Kanellopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Lundmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Abouzayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo Jacopo Ilic","family":"Balestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther Olaniran","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke R.","family":"Odell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Tolmachev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrika","family":"Rosenstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6120-2683","authenticated-orcid":false,"given":"Anna","family":"Orlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"336_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.apradiso.2014.05.001","volume":"91","author":"I AlJammaz","year":"2014","unstructured":"AlJammaz I, Al-Otaibi B, Abousekhrah A, Okarvi S. Rapid and one-step radiofluorination of bioactive peptides: potential PET radiopharmaceuticals. Appl Radiat Isot. 2014;91:17\u201323. https:\/\/doi.org\/10.1016\/j.apradiso.2014.05.001.","journal-title":"Appl Radiat Isot"},{"key":"336_CR2","doi-asserted-by":"publisher","unstructured":"Archibald SJ, Allott L. The aluminium-[18F]fluoride revolution: simple radiochemistry with a big impact for radiolabelled biomolecules. EJNMMI Radiopharm Chem. 2021;6. https:\/\/doi.org\/10.1186\/s41181-021-00141-0.","DOI":"10.1186\/s41181-021-00141-0"},{"key":"336_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11307-017-1151-1","volume":"20","author":"L Baratto","year":"2017","unstructured":"Baratto L, Jadvar H, Iagaru A. Prostate cancer theranostics targeting Gastrin-Releasing peptide receptors. Mol Imaging Biol. 2017;20:501\u20139. https:\/\/doi.org\/10.1007\/s11307-017-1151-1.","journal-title":"Mol Imaging Biol"},{"key":"336_CR4","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1021\/bc900240z","volume":"20","author":"J Becaud","year":"2009","unstructured":"Becaud J, Mu L, Karramkam M, Schubiger PA, Ametamey SM, Graham K, et al. Direct one-step 18F-labeling of peptides via nucleophilic aromatic substitution. Bioconjug Chem. 2009;20:2254\u201361. https:\/\/doi.org\/10.1021\/bc900240z.","journal-title":"Bioconjug Chem"},{"key":"336_CR5","doi-asserted-by":"publisher","first-page":"11117","DOI":"10.1002\/anie.201105547","volume":"50","author":"LS Campbell-Verduyn","year":"2011","unstructured":"Campbell-Verduyn LS, Mirfeizi L, Schoonen AK, Dierckx RA, Elsinga PH, Feringa BL. Strain-promoted copper-free click chemistry for 18F radiolabeling of Bombesin. Angew Chemie Int Ed Eng. 2011;50:11117\u201320. https:\/\/doi.org\/10.1002\/anie.201105547.","journal-title":"Angew Chemie Int Ed Eng"},{"key":"336_CR6","doi-asserted-by":"crossref","unstructured":"Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N et al. Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. Cancers (Basel). 2023;15:1631. https:\/\/www.mdpi.com\/2072-6694\/15\/6\/1631","DOI":"10.3390\/cancers15061631"},{"key":"336_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13550-023-01057-3","volume":"13","author":"P Cheung","year":"2023","unstructured":"Cheung P, Thorngren J, Zhang B, Vasylovska S, Lechi F, Persson J, et al. Preclinical evaluation of affibody molecule for PET imaging of human pancreatic Islets derived from stem cells. EJNMMI Res. 2023;13:107. https:\/\/doi.org\/10.1186\/s13550-023-01057-3.","journal-title":"EJNMMI Res"},{"key":"336_CR8","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1038\/s41596-018-0040-7","volume":"13","author":"F Cleeren","year":"2018","unstructured":"Cleeren F, Lecina J, Bridoux J, Devoogdt N, Tshibangu T, Xavier C, et al. Direct fluorine-18 labeling of heat-sensitive biomolecules for positron emission tomography imaging using the Al18F-RESCA method. Nat Protoc. 2018;13:2330\u201347. https:\/\/doi.org\/10.1038\/s41596-018-0040-7.","journal-title":"Nat Protoc"},{"key":"336_CR9","doi-asserted-by":"publisher","first-page":"647379","DOI":"10.3389\/fmed.2021.647379","volume":"8","author":"A D\u2019Onofrio","year":"2021","unstructured":"D\u2019Onofrio A, Silva F, Gano L, Karczmarczyk U, Miko\u0142ajczak R, Garnuszek P, et al. Clickable radiocomplexes with trivalent radiometals for cancer theranostics: in vitro and in vivo studies. Front Med. 2021;8:647379. https:\/\/doi.org\/10.3389\/fmed.2021.647379.","journal-title":"Front Med"},{"key":"336_CR10","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3390\/pharmaceutics14122569","volume":"14","author":"A D\u2019Onofrio","year":"2022","unstructured":"D\u2019Onofrio A, Silva F, Gano L, Raposinho P, Fernandes C, Sikora A, et al. Bioorthogonal chemistry approach for the theranostics of GRPR-Expressing cancers. Pharmaceutics. 2022;14:2569. https:\/\/doi.org\/10.3390\/pharmaceutics14122569.","journal-title":"Pharmaceutics"},{"key":"336_CR11","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1021\/jm400857f","volume":"56","author":"LO Dialer","year":"2013","unstructured":"Dialer LO, Selivanova SV, M\u00fcller CJ, M\u00fcller A, Stellfeld T, Graham K, et al. Studies toward the development of new silicon-containing Building blocks for the direct 18F-labeling of peptides. J Med Chem. 2013;56:7552\u201363. https:\/\/doi.org\/10.1021\/jm400857f.","journal-title":"J Med Chem"},{"key":"336_CR12","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1038\/nprot.2011.390","volume":"6","author":"HS Gill","year":"2011","unstructured":"Gill HS, Marik J. Preparation of 18F-labeled peptides using the copper(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition. Nat Protoc. 2011;6:1718\u201325. https:\/\/doi.org\/10.1038\/nprot.2011.390.","journal-title":"Nat Protoc"},{"key":"336_CR14","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1021\/bc800157h","volume":"19","author":"A H\u00f6hne","year":"2008","unstructured":"H\u00f6hne A, Mu L, Honer M, Schubiger PA, Ametamey SM, Graham K, et al. Synthesis, 18F-labeling, and in vitro and in vivo studies of Bombesin peptides modified with silicon-based Building blocks. Bioconjug Chem. 2008;19:1871\u20139. https:\/\/doi.org\/10.1021\/bc800157h.","journal-title":"Bioconjug Chem"},{"key":"336_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2967\/jnumed.110.081620","volume":"52","author":"M H\u00f6ner","year":"2011","unstructured":"H\u00f6ner M, Mu L, Stellfeld T, Graham K, Martic M, Fischer CR, et al. 18F-labeled Bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors. J Nucl Med. 2011;52:270\u20138. https:\/\/doi.org\/10.2967\/jnumed.110.081620.","journal-title":"J Nucl Med"},{"key":"336_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/bc500475e","volume":"26","author":"O Jacobson","year":"2015","unstructured":"Jacobson O, Kiesewetter DO, Chen X. Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjug Chem. 2015;26:1\u201318. https:\/\/doi.org\/10.1021\/bc500475e.","journal-title":"Bioconjug Chem"},{"key":"336_CR16","doi-asserted-by":"publisher","first-page":"18608","DOI":"10.1021\/acsomega.4c01348","volume":"9","author":"P Kanellopoulos","year":"2024","unstructured":"Kanellopoulos P, Bezverkhniaia E, Abouzayed A, Rosenstr\u00f6m U, Tolmachev V, Orlova A. Two novel [68Ga]Ga-Labeled radiotracers based on metabolically stable [Sar11]RM26 antagonistic peptide for diagnostic positron emission tomography imaging of GRPR-Positive prostate cancer. ACS Omega. 2024;9:18608\u201316. https:\/\/doi.org\/10.1021\/acsomega.4c01348.","journal-title":"ACS Omega"},{"key":"336_CR17","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1039\/c3ob40548f","volume":"11","author":"JC Knight","year":"2013","unstructured":"Knight JC, Richter S, Wuest M, Way JD, Wuest F. Synthesis and evaluation of an 18F-labelled Norbornene derivative for copper-free click chemistry reactions. Org Biomol Chem. 2013;11:3817\u201325. https:\/\/doi.org\/10.1039\/c3ob40548f.","journal-title":"Org Biomol Chem"},{"key":"336_CR20","first-page":"57","volume":"3","author":"Y Li","year":"2013","unstructured":"Li Y, Liu Z, Harwig CW, Pourghiasian M, Lau J, Lin K-S, et al. 18F-click labeling of a Bombesin antagonist with an alkyne-18F-ArBF3\u2013: in vivo PET imaging of tumors expressing the GRP-receptor. Am J Nucl Med Mol Imaging. 2013;3:57\u201370.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"336_CR18","doi-asserted-by":"publisher","unstructured":"Li K, Oderinde O, Liu S, Yao F, Fu G. Polymer synthesis: Copper-Catalyzed Azide alkyne cycloaddition. Encycl Polym Sci Technol. 2017;1\u201340. https:\/\/doi.org\/10.1002\/0471440264.PST662.","DOI":"10.1002\/0471440264.PST662"},{"key":"336_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jfluchem.2012.07.005","volume":"143","author":"X-G Li","year":"2021","unstructured":"Li X-G, Haaparanta M, Solin O. Oxime formation for fluorine-18 labeling of peptides and proteins for positron emission tomography (PET) imaging: A review. J Fluor Chem. 2021;143:49\u201356. https:\/\/doi.org\/10.1016\/j.jfluchem.2012.07.005.","journal-title":"J Fluor Chem"},{"key":"336_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2967\/jnumed.108.060418","volume":"50","author":"WJ Mcbride","year":"2009","unstructured":"Mcbride WJ, Sharkey RM, Karacay H, D\u2019souza CA, Rossi EA, Laverman P, et al. A novel method of 18F radiolabeling for PET. J Nucl Med. 2009;50:991\u20138. https:\/\/doi.org\/10.2967\/jnumed.108.060418.","journal-title":"J Nucl Med"},{"key":"336_CR22","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/ijc.32401","volume":"145","author":"B Mitran","year":"2019","unstructured":"Mitran B, Rinne SS, Konijnenberg MW, Maina T, Nock BA, Altai M, et al. Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu\u2010DOTAGA\u2010PEG2\u2010RM26. Int J Cancer. 2019;145:3347\u201358. https:\/\/doi.org\/10.1002\/ijc.32401.","journal-title":"Int J Cancer"},{"key":"336_CR23","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.2174\/0929867327666200312114902","volume":"27","author":"B Mitran","year":"2020","unstructured":"Mitran B, Tolmachev V, Orlova A. Radiolabeled GRPR antagonists for imaging of disseminated prostate Cancer - Influence of labeling chemistry on targeting properties. Curr Med Chem. 2020;27:7090\u2013111. https:\/\/www.eurekaselect.com\/180140\/article.","journal-title":"Curr Med Chem"},{"key":"336_CR24","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/bc100222u","volume":"21","author":"L Mu","year":"2010","unstructured":"Mu L, Honer M, Becaud J, Martic M, Schubiger PA, Ametamey SM, et al. In vitro and in vivo characterization of novel 18F-labeled Bombesin analogues for targeting GRPR-positive tumors. Bioconjug Chem. 2010;21:1864\u201371. https:\/\/doi.org\/10.1021\/bc100222u.","journal-title":"Bioconjug Chem"},{"key":"336_CR25","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/cmdc.201800334","volume":"13","author":"E Murrell","year":"2018","unstructured":"Murrell E, Kovacs MS, Luyt LG. A compact and synthetically accessible Fluorine-18 labelled cyclooctyne prosthetic group for labelling of biomolecules by Copper-Free click chemistry. ChemMedChem. 2018;13:1625\u20138. https:\/\/doi.org\/10.1002\/cmdc.201800334.","journal-title":"ChemMedChem"},{"key":"336_CR26","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.3390\/cancers13205093","volume":"13","author":"BA Nock","year":"2021","unstructured":"Nock BA, Kaloudi A, Kanellopoulos P, Janota B, Bromi\u0144ska B, I\u017cycki D, et al. [99mTc]Tc-DB15 in GRPR-Targeted tumor imaging with SPECT: from preclinical evaluation to the first clinical outcomes. Cancers (Basel). 2021;13:5093. https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5093.","journal-title":"Cancers (Basel)"},{"key":"336_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13550-015-0120-4","volume":"5","author":"A Paulus","year":"2015","unstructured":"Paulus A, Desai P, Carney B, Carlucci G, Reiner T, Brand C, et al. Development of a clickable bimodal fluorescent\/pet probe for in vivo imaging. EJNMMI Res. 2015;5:120. https:\/\/doi.org\/10.1186\/s13550-015-0120-4.","journal-title":"EJNMMI Res"},{"key":"336_CR28","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.bmc.2015.02.009","volume":"23","author":"M Pourghiasian","year":"2015","unstructured":"Pourghiasian M, Liu Z, Pan J, Zhang Z, Colpo N, Lin KS, et al. 18F-AmBF3-MJ9: A novel radiofluorinated Bombesin derivative for prostate cancer imaging. Bioorg Med Chem. 2015;23:1500\u20136. https:\/\/doi.org\/10.1016\/j.bmc.2015.02.009.","journal-title":"Bioorg Med Chem"},{"key":"336_CR29","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.nucmedbio.2013.07.005","volume":"40","author":"S Richter","year":"2013","unstructured":"Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, et al. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled Bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Nucl Med Biol. 2013;40:1025\u201334. https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.07.005.","journal-title":"Nucl Med Biol"},{"key":"336_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1021\/bc500599m","volume":"26","author":"S Richter","year":"2015","unstructured":"Richter S, Wuest M, Bergman CN, Way JD, Krieger S, Rogers BE, et al. Rerouting the metabolic pathway of 18F-labeled peptides: the influence of prosthetic groups. Bioconjug Chem. 2015;26:201\u201312. https:\/\/doi.org\/10.1021\/bc500599m.","journal-title":"Bioconjug Chem"},{"key":"336_CR31","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1021\/bc3002425","volume":"23","author":"K Sachin","year":"2012","unstructured":"Sachin K, Jadhav VH, Kim EM, Kim HL, Lee SB, Jeong HJ, et al. F-18 labeling protocol of peptides based on chemically orthogonal strain-promoted cycloaddition under physiologically friendly reaction conditions. Bioconjug Chem. 2012;23:1680\u20136. https:\/\/doi.org\/10.1021\/bc3002425.","journal-title":"Bioconjug Chem"},{"key":"336_CR32","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1021\/bc700195y","volume":"18","author":"E Schirrmacher","year":"2007","unstructured":"Schirrmacher E, W\u00e4ngler B, Cypryk M, Bradtm\u00f6ller G, Sch\u00e4fer M, Eisenhut M, et al. Synthesis of p-(Di-tert-butyl[18F]fluorosilyl)benzaldehyde ([18F]SiFA-A) with high specific activity by isotopic exchange: A convenient labeling synthon for the 18F-labeling of N-amino-oxy derivatized peptides. Bioconjug Chem. 2007;18:2085\u20139. https:\/\/doi.org\/10.1021\/bc700195y.","journal-title":"Bioconjug Chem"},{"key":"336_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41181-024-00250-6","volume":"9","author":"E Schlein","year":"2024","unstructured":"Schlein E, Rokka J, Odell LR, van den Broek SL, Herth MM, Battisti UM, et al. Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET. EJNMMI Radiopharm Chem. 2024;9:21. https:\/\/doi.org\/10.1186\/s41181-024-00250-6.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"336_CR34","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.7150\/thno.14958","volume":"6","author":"C Stoykow","year":"2016","unstructured":"Stoykow C, Erbes T, Maecke HR, Bulla S, Bartholom\u00e4 M, Mayer S, et al. Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET. Theranostics. 2016;6:1641\u201350. http:\/\/www.thno.org\/v06p1641.htm.","journal-title":"Theranostics"},{"key":"336_CR35","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1021\/acschemneuro.0c00652","volume":"11","author":"S Syv\u00e4nen","year":"2020","unstructured":"Syv\u00e4nen S, Fang XT, Faresj\u00f6 R, Rokka J, Lannfelt L, Olberg DE, et al. Fluorine-18-Labeled antibody ligands for PET imaging of Amyloid-\u03b2 in brain. ACS Chem Neurosci. 2020;11:4460\u20138. https:\/\/doi.org\/10.1021\/acschemneuro.0c00652.","journal-title":"ACS Chem Neurosci"},{"key":"336_CR36","doi-asserted-by":"publisher","first-page":"e81932","DOI":"10.1371\/journal.pone.0081932","volume":"8","author":"Z Varasteh","year":"2013","unstructured":"Varasteh Z, \u00c5berg O, Velikyan I, Lindeberg G, S\u00f6rensen J, Larhed M, et al. In vitro and in vivo evaluation of a 18F-Labeled high affinity NOTA conjugated Bombesin antagonist as a PET ligand for GRPR-Targeted tumor imaging. PLoS ONE. 2013a;8:e81932. https:\/\/doi.org\/10.1371\/journal.pone.0081932.","journal-title":"PLoS ONE"},{"key":"336_CR37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1021\/bc300659k","volume":"24","author":"Z Varasteh","year":"2013","unstructured":"Varasteh Z, Velikyan I, Lindeberg G, S\u00f6rensen J, Larhed M, Sandstr\u00f6m M, et al. Synthesis and characterization of a High-Affinity NOTA-Conjugated Bombesin antagonist for GRPR-Targeted tumor imaging. Bioconjug Chem. 2013b;24:1144\u201353. https:\/\/doi.org\/10.1021\/bc300659k.","journal-title":"Bioconjug Chem"},{"key":"336_CR38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.nucmedbio.2014.12.009","volume":"42","author":"Z Varasteh","year":"2015","unstructured":"Varasteh Z, Mitran B, Rosenstr\u00f6m U, Velikyan I, Rosestedt M, Lindeberg G, et al. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist PEG 2 -RM26. Nucl Med Biol. 2015;42:446\u201354. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805114005745.","journal-title":"Nucl Med Biol"},{"key":"336_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41181-023-00210-6","volume":"8","author":"O Wegrzyniak","year":"2023","unstructured":"Wegrzyniak O, Zhang B, Rokka J, Rosestedt M, Mitran B, Cheung P, et al. Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an affibody molecule targeting platelet derived growth factor receptor \u0392. EJNMMI Radiopharm Chem. 2023;8:23. https:\/\/doi.org\/10.1186\/s41181-023-00210-6.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"336_CR40","doi-asserted-by":"publisher","first-page":"109688","DOI":"10.1016\/j.isci.2024.109688","volume":"27","author":"O Wegrzyniak","year":"2024","unstructured":"Wegrzyniak O, Lechi F, Mitran B, Korsgren O, Zhang B, Eriksson O. Non-invasive PET imaging of liver fibrogenesis using a RESCA-conjugated affibody molecule. iScience. 2024;27:109688. https:\/\/doi.org\/10.1016\/j.isci.2024.109688.","journal-title":"iScience"},{"issue":"4","key":"336_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.7150\/thno.7324","volume":"4","author":"G Wieser","year":"2014","unstructured":"Wieser G, Mansi R, Grosu AL, Schultze-Seemann W, Dumont-Walter RA, Meyer PT, et al. Positron emission tomography (PET) imaging of prostate cancer with a Gastrin releasing peptide receptor Antagonist - from mice to men. Theranostics. 2014;4(4):412. https:\/\/doi.org\/10.7150\/thno.7324.","journal-title":"Theranostics"},{"key":"336_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.7150\/thno\/v01p0220","volume":"1","author":"M Yang","year":"2011","unstructured":"Yang M, Gao H, Zhou Y, Ma Y, Quan Q, Lang L, et al. F-Labeled GRPR agonists and antagonists: A comparative study in prostate cancer imaging. Theranostics. 2011;1:220\u20139. https:\/\/doi.org\/10.7150\/thno\/v01p0220.","journal-title":"Theranostics"},{"key":"336_CR43","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1158\/0008-5472.CAN-03-3845","volume":"64","author":"H Zhang","year":"2004","unstructured":"Zhang H, Chen J, Waldherr C, Hinni K, Waser B, Reubi JC, et al. Synthesis and evaluation of Bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting Bombesin receptor-expressing tumors. Cancer Res. 2004;64:6707\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-3845.","journal-title":"Cancer Res"},{"key":"336_CR44","first-page":"492","volume":"47","author":"X Zhang","year":"2006","unstructured":"Zhang X, Cai W, Cao F, Schreibmann E, Wu Y. 18F-Labeled Bombesin analogs for targeting GRP Receptor-Expressing prostate cancer. J Nucl Med. 2006;47:492\u2013501.","journal-title":"J Nucl Med"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-025-00336-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-025-00336-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-025-00336-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T11:00:06Z","timestamp":1742986806000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmipharmchem.springeropen.com\/articles\/10.1186\/s41181-025-00336-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1186\/s41181-025-00336-9","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In vivo studies (NMRI and BALB\/C nu\/nu mice) complied with the European guidelines for laboratory animal protection. The ethics committee for animal research in Uppsala (Sweden) approved the experimental protocols; permit number 00473\/21.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}